NCT02355925View on ClinicalTrials.gov

Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Frozen Embryo Transfer on Cycle Outcomes

PHASE3CompletedINTERVENTIONAL

Enrollment

180

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Infertility

Interventions

DRUG

intrauterine injection of uhCG

40 μL of tissue culture medium (G.2plus ref. 10132, Vitrolife) containing either 500 IU of hCG (Choriomon®, IBSA SA, Switzerland) is injected intrauterine, approximately 7 minutes before embryo transfer.

DRUG

Placebo

only 40 μL of tissue culture medium (G.2plus ref. 10132, Vitrolife) is injected intrauterine, approximately 7 minutes before embryo transfer.

OTHER

control

the embryonic transfer is done without the intrauterine hCG injection. The ET procedure is performed just like in the other two groups.

Trial Locations (1)

Unknown

Royan Institute, Tehran

All Listed Sponsors

lead

Royan Institute

OTHER_GOV

NCT02355925 - Intrauterine Injection of Human Chorionic Gonadotropin Injection (hCG) Before Frozen Embryo Transfer on Cycle Outcomes | Biotech Hunter | Biotech Hunter